Changes in PCSK 9 and apolipoprotein B100 in Niemann–Pick disease after enzyme replacement therapy with olipudase alfa

BACKGROUND: Enzyme replacement therapy (ERT) with olipudase alfa, a recombinant human acid sphingomyelinase (rhASM), is being developed to treat patients with ASM deficiency (ASMD), commonly known as Niemann–Pick disease (NPD) types A or B. This study assessed the effect of ERT on lipid parameters a...

Descripción completa

Detalles Bibliográficos
Autores principales: Garside, Bethanie, Ho, Jan Hoong, Kwok, See, Liu, Yifen, Dhage, Shaishav, Donn, Rachelle, Iqbal, Zohaib, Jones, Simon A., Soran, Handrean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913414/
https://www.ncbi.nlm.nih.gov/pubmed/33639994
http://dx.doi.org/10.1186/s13023-021-01739-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913414/
https://www.ncbi.nlm.nih.gov/pubmed/33639994
http://dx.doi.org/10.1186/s13023-021-01739-y

Ejemplares similares